SIRT1 and breast cancer: Another report demonstrated that inhibition of SIRT1 reduced aromatase mRNA and protein levels in estrogen receptor negative (ER−) breast cancer cells possibly due to loss of ERRα binding to the aromatase promoter and subsequent inhibition of aromatase transcription (Holloway et al., 2013).